Sign in

You're signed outSign in or to get full access.

James Madden

Chair of the Board at GenpactGenpact
Board

About James Madden

Independent Chair of Genpact Limited’s Board since 2005; age 63. Background includes founding operator and investor roles in technology-enabled services, with prior CEO experience. The Board affirms his independence under NYSE standards; all nominees other than the CEO are independent. Tenure spans 20 years, providing deep institutional knowledge balanced by the Board’s structured refreshment and evaluation processes.

Past Roles

OrganizationRoleTenureCommittees/Impact
Carrick Capital Partners, LLCCo-founder and Co-CEO2012–presentGrowth-stage investing; operator-led value creation in tech-enabled services
Madden Capital PartnersFounder, Managing Partner2005–2012Advisory and investment leadership
Accretive LLCPartner2007–2011Company-building in services software
General Atlantic LLCSpecial Advisor2005–2007Strategic advisory to growth equity platforms
Exult, Inc.Chair and CEO1998–2005Built HR BPO category; public company leadership

External Roles

OrganizationRoleTenureNotes
ServiceSource International, Inc.Director (Past)Not disclosedPast public company board
Accolade, Inc.Director (Past)Not disclosedPast public company board

Board Governance

  • Roles: Independent Chair; member—Compensation Committee; member—Nominating & Governance (N&G) Committee. Chairs are Carol Lindstrom (Compensation) and Laura Conigliaro (N&G). Audit chaired by Mark Verdi.
  • Independence: Separate CEO and Chair structure; regular executive sessions presided by the independent Chair.
  • Attendance and engagement: Board met 8 times in 2024; all directors attended ≥75%, avg. 91%. Directors attended 2024 AGM.
  • Evaluations: Annual board/committee/individual evaluation overseen by N&G; 2024 results indicate effective operation.
  • ESG and risk oversight: N&G oversees ESG; Audit oversees cybersecurity/data privacy risk with quarterly reporting.
  • Shareholder alignment: No poison pill, proxy access, one-share-one-vote, active shareholder engagement.

Fixed Compensation

Director compensation emphasizes equity over cash, with additional retainers for Board Chair and committee service.

Component20232024
Annual Director Retainer (cash + RSUs)$270,000 total; RSUs $200,000 value; remaining in cash $280,000 total; RSUs $210,000 value; remaining in cash
Board Chair Retainer (cash)$65,000 $65,000
Board Chair RSU Grant (value)$120,000 RSUs $120,000 RSUs
Committee Membership Retainers (annual)Audit $22,500; Comp $17,500; N&G $17,500 Audit $22,500; Comp $17,500; N&G $17,500
Committee Chair Retainers (annual)Audit $47,500; Comp $32,500; N&G $32,500 Audit $47,500; Comp $32,500; N&G $32,500

James Madden – actual 2023 vs 2024 compensation and grant details:

Metric20232024
Fees earned (cash)$170,000 $170,000
Stock awards (grant-date fair value)$319,948 $329,976
Total$489,948 $499,976
RSU grant dateMay 4, 2023 May 2, 2024
RSUs granted (shares)7,865 10,539
RSU vest dateDec 31, 2023 Dec 31, 2024
Share issuance date (for vested RSUs)Dec 31, 2024 Dec 31, 2025

Governance features: annual comp cap $750,000; trading windows; prohibition on hedging/pledging; director ownership guidelines—raised from 3x to 5x annual cash retainer in 2024; five-year phase-in; as of 12/31/2024, all non-employee directors met guidelines except new appointee.

Performance Compensation

Non-employee directors do not receive performance-based cash bonuses or PSUs; RSUs are time-based. No meeting fees or non-equity incentive compensation; no pension or deferred comp for directors.

Other Directorships & Interlocks

  • Current public company directorships: None disclosed for Madden.
  • Past public boards: ServiceSource International, Accolade, Inc.
  • Related party transactions: None involving directors in 2023; 2024 disclosed only a non-executive family employment; Audit Committee reviews and approves any related person transactions.
  • Interlocks with competitors/suppliers/customers: None disclosed.

Expertise & Qualifications

  • Senior leadership experience; public company board experience; finance/accounting/risk management; innovation/technology; investment expertise (skills matrix).

Equity Ownership

MetricAs of Mar 8, 2024As of Mar 25, 2025
Beneficial ownership (shares)44,947 direct + 7,865 vested RSUs deliverable 12/31/2024 = 52,812 total 44,947 direct + 10,539 vested RSUs deliverable 12/31/2025 = 55,486 total
Shares outstanding (reference)180,333,144 174,870,928
Ownership % of outstanding~0.0293% (52,812 / 180,333,144) ~0.0317% (55,486 / 174,870,928)
Vested vs. unvestedRSUs vested at year-end; no unvested RSUs/options for non-employee directors as of 12/31/2024
Hedging/pledgingProhibited by insider trading policy
Ownership guidelines complianceDirectors required to hold ≥5x annual cash retainer; all non-employee directors (except new appointee) met requirement as of 12/31/2024

Governance Assessment

  • Strengths: Independent Chair; separate CEO/Chair; robust committee structure with independent membership; regular executive sessions; strong attendance; annual evaluations; stringent director ownership guidelines; prohibition on hedging/pledging; no poison pill; active shareholder engagement. These features support board effectiveness and investor alignment.
  • Compensation alignment: Director pay is equity-heavy (annual RSUs plus Chair RSUs), reinforcing long-term value creation. Year-over-year updates increased RSU value and ownership multiple—favorable alignment signals.
  • Risks/RED FLAGS to monitor: Long tenure (20 years) can pose entrenchment risk; mitigated by active refreshment, median tenure 7.5 years, and annual evaluations. No related party transactions involving directors and no Section 16 delinquency noted for Madden.
  • Shareholder mood: Say-on-pay approval ~91% in 2024 indicates broad investor support for compensation practices, reflecting overall governance credibility.